Collagen-Stimulating Injectable
Sculptra (PLLA) in Seoul
Collagen-Stimulating Volume Restoration
Sculptra in Seoul offers gradual volume restoration, facial balance, and dermatologist-led anti-aging planning in Gangnam.

Board-Certified Dermatologist
Dr. SangYoul Yun
AAD International Fellow
IFAAD
- Duration
- Set after assessment
- Sessions
- No universal course
- Downtime
- Varies by plan

Sculptra Treatment in Seoul
Results Over Time
Sculptra works gradually. The key is whether it fits the patient's concern, facial structure, and timeline rather than trend.
1Day 0–3
Mild swelling and possible bruising.
2Week 4–8
Subtle visible change as the collagen response begins.
3Month 3–6
Change continues to build gradually.
4Follow-up
Any further treatment is decided after the response is reviewed.
Sculptra Collagen Booster
Galderma's Sculptra is a poly-L-lactic acid (PLLA) injectable. Placed in the deep dermis or the layer just below it, it stimulates the body's own collagen gradually over a course of sessions.

PLLA Biostimulator
Poly-L-lactic acid stimulates your own collagen in the deep dermis.
Gradual Change
Collagen builds over months, so change appears gradually rather than right after treatment.
Individual Plan
The number of sessions and any later treatment are decided after reviewing how your skin responds.
Treatment Process
1Clinical Assessment
Consultation starts with the actual concern: support, hollowing, skin quality, or laxity.
2Modality Selection
The dermatologist reviews whether Sculptra, filler, a device, or a booster is the better starting point.
3Treatment Planning
Injection planning, timeline, and follow-up spacing are reviewed before treatment.
4Staged Treatment
A staged plan is discussed when gradual treatment makes more sense than a one-visit approach.
Treatment explained
How Sculptra (PLLA) is injected under the cheek skin
Sculptra powder is prepared by mixing it with sterile water for injection.
Film guide (1–9)
What the numbers show
- 1. Cheek · example injection area
- 2. Example entry point
- 3. Needle
- 4. Epidermis
- 5. Dermis
- 6. Subcutaneous fat
- 7. Muscle layer
- 8. Injection site
- 9. Injection site in the subcutaneous layer
In the film
- A fine needle enters beneath the cheek skin.
- The injection goes into the subcutaneous layer.
- A little is injected as the needle is withdrawn.
Recovery & Care
First 72h
Cold compress for swelling. No firm massage until Day 3.
After treatment (5-5-5 rule)
Gently massage each treated area 5 minutes, 5× per day, for 5 days.
Week 4
Follow-up to plan the next session.
Follow-up
Any further session is planned after the response is reviewed.

Frequently Asked Questions
Q.What is Sculptra Aesthetic?
The U.S. FDA PMA record identifies Sculptra Aesthetic as an injectable dermal implant containing poly-L-lactic acid. The U.S. record has a defined indication and does not by itself establish Korean authorization, clinic availability, or suitability for another treatment area.
Q.Is Sculptra the same as hyaluronic-acid filler?
No. It is an injectable PLLA implant, not hyaluronic-acid filler. The onset, correction strategy, reversibility discussion, and follow-up are different, so the choice should follow examination rather than a universal comparison claim.
Q.How many sessions are needed, and when is the result visible?
The proposed area, baseline concern, response, prior treatment, and ability to follow up should determine whether treatment proceeds and whether any additional session is appropriate.
Q.How long does Sculptra last?
Published study follow-up does not create a guaranteed duration for an individual patient or treatment area. Durability varies, and a maintenance interval should not be promised before response is assessed.
Q.What risks should be discussed?
U.S. physician labeling lists injection-site swelling, tenderness, redness, pain, bruising, bleeding, papules or nodules, inflammation, and infection risk, and warns against injection into blood vessels. Personal risk and urgent warning signs require clinician-specific consent.
Q.How should an international patient plan follow-up?
Plan for possible visible recovery and agree on local or remote escalation before treatment. Delayed lumps, nodules, inflammation, increasing pain, or color change should not wait for a future trip to be assessed.
References3
The clinical claims on this page (device specs, efficacy timelines, safety profile) are supported by the primary sources below. Each citation links to the original paper or regulatory record.
- [1]Sculptra Aesthetic PMA Supplement S002. U.S. Food and Drug Administration (2009).
- [2]Sculptra Aesthetic: U.S. Physician Labeling. U.S. Food and Drug Administration (2009).
- [3]Injectable Poly-L-Lactic Acid Versus Human-Based Collagen Implant for Nasolabial Fold Wrinkles. Journal of the American Academy of Dermatology (2010).
Notice
- Do not use in a person with hypersensitivity to a product component or a known history of or susceptibility to keloid formation or hypertrophic scarring, per U.S. labeling.
- Defer treatment at a site with active inflammation or infection until it has resolved and is controlled.
- Pregnancy, breastfeeding, bleeding risk, immune or connective-tissue conditions, prior implants, and prior procedures require individual review because evidence or suitability may be limited.
- Do not proceed when adequate consent, recovery time, or follow-up cannot be arranged.
Session summary & comparison
| Item | Details |
|---|---|
| Duration | Set after assessment |
| Sessions | No universal course |
| Downtime | Varies by plan |
| Peak result | Reassessed over time |
Related procedures
Evidence & comparison guides
Need another answer before deciding?
You do not need to read every guide. Open the question that still matters to your decision.
Notice: Individual results may vary depending on skin condition, treatment history, and recovery factors. All treatment plans are determined through individual consultation with a board-certified dermatologist. The information on this page is for reference only and does not constitute medical advice or guarantee specific outcomes.
Next Step


